US Patent 9815886 Compositions and methods for the treatment of immunodeficiency
Patent 9815886 was granted and assigned to Adma Biologics, Inc. on November, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9815886 Compositions and methods for the treatment of immunodeficiency
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
